ID   OMC-2
AC   CVCL_3353
SY   OMC2; Osaka Medical College-2
DR   CLO; CLO_0050887
DR   BioSample; SAMN03471931
DR   Cosmic; 1152551
DR   FANTOM5_SSTAR; 10497-107C2
DR   GEO; GSM2599690
DR   GEO; GSM2599691
DR   RCB; RCB2830
DR   Wikidata; Q54932033
RX   PubMed=2624581;
RX   PubMed=29872505;
CC   Population: Japanese.
CC   Doubling time: 55-139 hours (PubMed=2624581).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
ST   Source(s): RCB=RCB2830
ST   Amelogenin: X
ST   CSF1PO: 9,12
ST   D13S317: 11
ST   D16S539: 11
ST   D5S818: 11,12
ST   D7S820: 8,10
ST   TH01: 7
ST   TPOX: 9,12
ST   vWA: 15
DI   NCIt; C7359; Endometrial adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   59Y
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 10-04-25; Version: 17
//
RX   PubMed=2624581; DOI=10.1111/j.1447-0756.1989.tb00206.x;
RA   Yamada T., Ueda M., Maeda T., Okamoto Y., Miyawaki Y., Otsuki Y.,
RA   Ueki M., Sugimoto O.;
RT   "Establishment and characterization of CA 125 producing cell line
RT   (OMC-2) originating from a human endometrial adenocarcinoma.";
RL   Asia Oceania J. Obstet. Gynaecol. 15:403-416(1989).
//
RX   PubMed=29872505; DOI=10.18632/oncotarget.25349; PMCID=PMC5973852;
RA   Takeshita S., Yamashita Y., Shiomi K., Suzuki N., Yoshida J.,
RA   Naiki-Ito A., Suzuki S., Akatsuka S., Toyokuni S., Takahashi T.,
RA   Mase S., Arakawa A., Sugiura-Ogasawara M., Takahashi S.;
RT   "Expression of P-REX2a is associated with poor prognosis in
RT   endometrial malignancies.";
RL   Oncotarget 9:24778-24786(2018).
//